Journal of Cellular and Molecular Medicine · 2018 · 27 citations · 44 references
MedicineCancer BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyCancer TranscriptomicsMicrorna BiologyMicrorna-mediated RegulationOncogenic Signaling PathwaysOral CarcinogenesisBile Acid-mediated CarcinogenesisMicrorna DeregulationMicrorna In CancerMicrorna ModulationMicrorna-mediated DeregulationMicrorna-mediated OncogenesisMicrorna-mediated Pathway RegulationTranscriptional Activation
We previously demonstrated that acidic bile activates NF-κB, deregulating the expression of oncogenic miRNA markers, in pre-malignant murine laryngopharyngeal mucosa. Here, we hypothesize that the in vitro exposure of human hypopharyngeal cells to acidic bile deregulates cancer-related miRNA markers that can be reversed by BAY 11-7082, a pharmacologic NF-κB inhibitor. We repetitively exposed normal human hypopharyngeal primary cells and human hypopharyngeal keratinocytes to bile fluid (400 μmol/L), at pH 4.0 and 7.0, with/without BAY 11-7082 (20 μmol/L). We centred our study on the transcriptional activation of oncogenic miR-21, miR-155, miR-192, miR-34a, miR-375, miR-451a and NF-κB-related genes, previously linked to acidic bile-induced pre-neoplastic events. Our novel findings in vitro are consistent with our hypothesis demonstrating that BAY 11-7082 significantly reverses the acidic bile-induced oncogenic miRNA phenotype, in normal hypopharyngeal cells. BAY 11-7082 strongly inhibits the acidic bile-induced up-regulation of miR-192 and down-regulation of miR-451a and significantly decreases the miR-21/375 ratios, previously related to poor prognosis in hypopharyngeal cancer. This is the first in vitro report that NF-κB inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in normal human hypopharyngeal cells, suggesting that acidic bile-induced events are directly or indirectly dependent on NF-κB signalling.
44
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
Jacqueline W. Pierce, Robert Schoenleber, Gary Jesmok et al. · Journal of Biological Chemistry · 1997 · 1.1K citations · Full text